LRRK2 G2019S mutation in Parkinson’s disease: A neuropsychological and neuropsychiatric study in a large Algerian cohort

Eriksen, 2005, Molecular pathogenesis of Parkinson’s disease, Arch Neurol, 62, 353, 10.1001/archneur.62.3.353 Elbaz, 1999, Familial aggregation of Parkinson’s disease: a population-based case-control study in Europe. EUROPARKINSON study group, Neurology, 52, 1876, 10.1212/WNL.52.9.1876 Lesage, 2009, Parkinson’s disease: from monogenic forms to genetic susceptibility factors, Hum Mol Genet, 18, 48, 10.1093/hmg/ddp012 Lesage, 2006, LRRK2 G2019S as a cause of Parkinson’s disease in North African Arabs, N Engl J Med, 354, 422, 10.1056/NEJMc055540 Brice, 2005, Genetics of Parkinson’s disease: LRRK2 on the rise, Brain, 128, 2760, 10.1093/brain/awh676 Ozelius, 2006, LRRK2 G2019S as a cause of Parkinson’s disease in Ashkenazi Jews, N Engl J Med, 354, 424, 10.1056/NEJMc055509 Lesage, 2008, Is the common LRRK2 G2019S mutation related to dyskinesias in North African Parkinson’s disease?, Neurology, 71, 1550, 10.1212/01.wnl.0000338460.89796.06 Lechevallier-Michel, 2004, Normative data for the MMSE, the Benton visual retention test, the Isaacs’s set test, the digit symbol substitution test and the Zazzo’s cancellation task in subjects over the age 70: results from the PAQUID Study, Rev Neurol (Paris), 160, 1059, 10.1016/S0035-3787(04)71143-1 Dessi, 2009, Assessment of episodic memory in illiterate elderly, Psychol Neuropsychiatr Vieil, 7, 287 Buschke, 1999, Screening for dementia with the memory impairment screen, Neurology, 52, 231, 10.1212/WNL.52.2.231 Goldwurm, 2006, LRRK2 G2019S mutation and Parkinson’s disease: a clinical, neuropsychological and neuropsychiatric study in a large Italian sample, Parkinsonism Relat Disord, 12, 410, 10.1016/j.parkreldis.2006.04.001 Lesage, 2005, G2019S LRRK2 mutation in French and North African families with Parkinson’s disease, Ann Neurol, 58, 784, 10.1002/ana.20636 Ngandu, 2007, Education and dementia: what lies behind the association?, Neurology, 69, 1442, 10.1212/01.wnl.0000277456.29440.16 Remy, 2005, Depression in Parkinson’s disease: loss of dopamine and noradrenaline innervation in the limbic system, Brain, 128, 1314, 10.1093/brain/awh445 Kumar, 2002, Sleep disorders in Parkinson’s disease, Mov Disord, 17, 775, 10.1002/mds.10167 Allain, 2005, Rôle de l’âge sur les performances à quatre tests explorant le fonctionnement exécutif. Résultats chez les sujets sains, L’année gérontologique, 78